Regulations.gov document
Raw Data for Safety and Effectiveness Studies; Draft Guidance for Industry
Other · FDA-2024-D-1613 · posted Apr 29, 2024
Key facts
| Document ID | FDA-2024-D-1613-0002 |
|---|---|
| Title | Raw Data for Safety and Effectiveness Studies; Draft Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2024-D-1613 |
| Posted | Apr 29, 2024 |
| Comment period opens | Apr 29, 2024 |
| Comments due | Jun 29, 2024 |
At a glance
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: